IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 77 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.64 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $27,000 | -18.2% | 20,113 | +11.5% | 0.00% | – |
| Q1 2018 | $33,000 | -25.0% | 18,033 | -13.9% | 0.00% | – |
| Q4 2017 | $44,000 | +51.7% | 20,942 | +75.5% | 0.00% | – |
| Q1 2017 | $29,000 | +16.0% | 11,934 | -28.3% | 0.00% | – |
| Q4 2016 | $25,000 | +47.1% | 16,652 | +52.9% | 0.00% | – |
| Q2 2016 | $17,000 | -19.0% | 10,890 | +4.1% | 0.00% | – |
| Q1 2016 | $21,000 | -44.7% | 10,464 | -15.9% | 0.00% | – |
| Q4 2015 | $38,000 | -5.0% | 12,443 | +15.4% | 0.00% | -100.0% |
| Q2 2015 | $40,000 | -35.5% | 10,786 | -35.1% | 0.00% | 0.0% |
| Q1 2015 | $62,000 | +8.8% | 16,625 | +28.8% | 0.00% | 0.0% |
| Q4 2014 | $57,000 | +3.6% | 12,906 | -46.0% | 0.00% | 0.0% |
| Q3 2014 | $55,000 | -35.3% | 23,900 | -18.5% | 0.00% | 0.0% |
| Q2 2014 | $85,000 | – | 29,309 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 4,525,000 | $7,874,000 | 1.40% |
| DAFNA Capital Management LLC | 200,000 | $348,000 | 0.38% |
| HealthCor Management, L.P. | 3,270,000 | $5,690,000 | 0.30% |
| Baker Brothers Advisors | 5,865,000 | $10,205,000 | 0.14% |
| Spark Investment Management LLC | 152,500 | $262,000 | 0.06% |
| NATIXIS | 3,148,916 | $5,479,000 | 0.06% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 371,759 | $647,000 | 0.05% |
| LEAVELL INVESTMENT MANAGEMENT, INC. | 81,271 | $141,000 | 0.02% |
| TFS CAPITAL LLC | 118,232 | $206,000 | 0.01% |
| First Eagle Investment Management, LLC | 1,434,296 | $2,496,000 | 0.01% |